Pancreatic and bile duct cancer circulating tumor cells (CTC) form immune-resistant multi-cell type clusters in the portal venous circulation

References

• Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17(4):991–997. doi:10.1245/s10434-009-0883-9.
   PubMed Web of Science ®Google Scholar
• Kanarajah SK. Pancreaticoduodenectomy for periampullary tumours: a review article based on Surveillance, End Results and Epidemiology (SEER) database. Clin Transl Oncol. 2018. doi:10.1007/s12094-018-1832-5.
   Web of Science ®Google Scholar
• Ansari D, Friess H, Bauden M, Samnegard J, Anderson R. Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment. Oncotarget. 2018;9(5):6644–6651. doi:10.18632/oncotarget.24019.
   PubMedGoogle Scholar
• Eshlerman JR, Norris AL, Sadakai Y, Debeljak M, Borges M, Harrington C, Lin E, Brant A, Barkley T, Almario JA, et al. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. Clin Gastroenterol Hepatol. 2015;13(5):963–969.e4. doi:10.1016/j.cgh.2014.11.028.
   PubMed Web of Science ®Google Scholar
• Foley K, Kim V, Jaffee E, Zheng L. Current progress in immunotherapy for pancreatic cancer. Cancer Lett. 2016;381(1):244–251. doi:10.1016/j.canlet.2015.12.020.
   PubMed Web of Science ®Google Scholar
• Arnoletti JP, Zhu X, Almodovar AJO, Veldhuis PP, Sause R, Griffith E, Corpus G, Chang JCC, Fanaian N, Litherland SA. Portal venous blood circulation supports immunosuppressive environment and pancreatic cancer circulating tumor cell activation. Pancreas. 2017;46(1):p 116–123. doi:10.1097/MPA.0000000000000667.
   PubMed Web of Science ®Google Scholar
• Epelboym I, DiNorcia J, Winner M, Lee MK, Lee JA, Schrope BA, Chabot JA, Allendorf JD. Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancer. World J Surg. 2014;38:1184–1195. doi:10.1007/s00268-013-2384-z.
   PubMed Web of Science ®Google Scholar
• Baker LA, Tiriac H, Clevers H, Tuveson DA. Modeling pancreatic cancer with organoids. Trends in Cancer/Cell. 2016;2(4):176–190. doi:10.1016/j.trecan.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Cheung KJ, Ewald AJ. A collective route to metastasis: seeding by tumor cell clusters. Science. 2016;352(6282):167–169. doi:10.1126/science.aaf6546.
   PubMed Web of Science ®Google Scholar
• Pilling D, Gomer RH. Differentiation of circulating monocytes into fibroblast-like cells. Methods Mol Biol. 2012;904:191–206. doi:10.1007/978-1-61779-943-3_16.
   PubMedGoogle Scholar
• Yang J, Lin S-C, Chen G, He L, Hu Z, Chan L, Trial J, Entman ML, Wang Y. Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis. J Am Soc Nephrol. 2013;24(10):644–1659. doi:10.1681/ASN.2013030217.
   Web of Science ®Google Scholar
• Metcalf D. The molecular biology and function of the granulocyte-macrophage colony-stimulating factors. Blood. 1986;67(2):257–267.
   PubMed Web of Science ®Google Scholar
• Sherman MH, Yu RT, Tseng TW, Sousa CM, Liu S, Truitt ML, He N, Ding N, Liddle C, Atkins AR, et al. Stromal cues regulate the pancreatic cancer epigenome and metabolome. PNAS. 2016;114(50):1129–1134. doi:10.1073/pnas.1620164114.
   Google Scholar
• Dimeloe S, Mehling M, Frick C, Loeliger J, Bantug GR, Sauder U, Fischer M, Belle R, Develioghi L, Tay S, et al. The immune-metabolic basis of effector memory CD4 + T cell function under hypoxic conditions. J Immunol. 2016;196(1):106–114. doi:10.4049/jimmunol.1501766.
   PubMed Web of Science ®Google Scholar
• Eom DS, Parichy DM. A macrophage relay for long-distance signaling during postembryonic tissue remodeling. Science. 2017;355(6331):1317–1319. doi:10.1126/science.aal2745.
   PubMed Web of Science ®Google Scholar
• Alvarez-Errico D, Vento-Tormo R, Sieweke M, Ballestar E. Epigenetic control of myeloid cell differentiation, identity and function. Nat Rev Immunol. 2015;15:7–17. doi:10.1038/nri3777.
   PubMed Web of Science ®Google Scholar
• Sarioglu AF, Aceto N, Kojic N, Donaldson MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto DT, et al. A microfluidic device for label-free, physical capture of circulating tumor cell-clusters. Nat Methods. 2015;12(7):685–691. doi:10.1038/nmeth.3404.
   PubMed Web of Science ®Google Scholar
• Au SH, Storey BD, Moore JC, Tang Q, Chen Y-L, Javaid S, Sarioglu AF, Sullivan R, Madden MW, O’Keefe R, et al. Clusters of circulating tumor cells traverse capillary-size vessels. PNAS. 2016;113(18):4947–4952. doi:10.1073/pnas.1524448113.
   PubMed Web of Science ®Google Scholar
• Kurosaki I, Kawachi Y, Nihei K, Tsuchiya Y, Aono T, Yokoyama N, Shimizu T, Hatakeyama K. Liver perfusion chemotherapy with 5-Fluorouracil followed by systemic gemcitabine administration for resected pancreatic cancer: preliminary results of a prospective phase 2 study. Pancreas. 2009;38(2):161–167. doi:10.1097/MPA.0b013e31818815f7.
   PubMed Web of Science ®Google Scholar
• Kitami C, Kurosaki I, Kawachi Y, Nihei K, Tsuchiya Y, Nomura T, Minagawa M, Takano K, Hatakeyama K. Niigata study group of pancreatic cancer. Portal vein infusion chemotherapy with gemcitabine after surgery for pancreatic cancer. Surg Today. 2013;43:33–39. doi:10.1007/s00595-012-0179-8.
   PubMed Web of Science ®Google Scholar
• Ito Y, Aiura K, Ueda M, Kitajima M, Kitagawa Y. Establishment of combined immune-chemotherapy with systemically administered gemcitabine and intra-portal administration of interleukin-2 in murine models of liver metastases of pancreatic cancer. Int J Oncol. 2008;33:49–58.
   PubMed Web of Science ®Google Scholar